TickerFacts.

biote Corp. (BTMD): Revenue

Annual figures by period end, from SEC filings.

$192.22M
Year ended 2025-12-31
$183.53M
Trailing 12 months to 2026-06-30
+5.2%
3-year compound annual growth
$197.19M2021-12-31: $139.40M2022-12-31: $164.96M2023-12-31: $185.36M2024-12-31: $197.19M2025-12-31: $192.22M$192.22M
2021-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$192.22M-2.5%2026-03-13, From 2025-01-01
2024-12-31$197.19M+6.4%2026-03-13, From 2024-01-01
2023-12-31$185.36M+12.4%2025-03-14, From 2023-01-01
2022-12-31$164.96M+18.3%2024-03-15, From 2022-01-01
2021-12-31$139.40Mn/a2023-03-29, From 2021-01-01

Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
biote Corp. (BTMD)2025-12-31$192.22M-2.5%
Glass House Brands Inc. (GLAS)2025-12-31$181.98M-9.4%
Marimed Inc. (MRMD)2025-12-31$159.83M+1.3%
Cronos Group Inc. (CRON)2025-12-31$146.59M+24.6%
Natural Alternatives International Inc (NAII)2026-06-30$142.51M+9.7%
Jushi Holdings Inc. (JUSH)2025-12-31$262.91M+2.1%
Niagen Bioscience, Inc. (NAGE)2025-12-31$129.42M+29.9%
Mannatech Inc (MTEX)2025-12-31$108.04M-8.3%
Fitlife Brands, Inc. (FTLF)2025-12-31$81.46M+26.4%

Compare BTMD, GLAS, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗